# Daily Plan

Handoff from `pre_market` → `market_open`. Rewritten fresh each pre-market. `market_close` archives the prior day's plan to `memory/archive/plan_<YYYY-MM-DD>.md`.

## Date

2026-11-09 (Monday) — pre_market run ~07:24 ET. **DRY_RUN: false.**

## Planned buys

| ticker | target_qty | limit_price | stop_price | thesis |
|--------|------------|-------------|------------|--------|
| _(none — no candidate scored ≥6/10 under the ELEVATED_BAR >20%-all-sectors bar; see Notes)_ | — | — | — | — |

## Planned sells

| ticker | reason | notes |
|--------|--------|-------|
| _(none — book is FLAT/all-cash, no open positions to exit)_ | — | — |

## Trailing stop conversions (market_open actions)

| ticker | current_stop_id | current_stop_price | action | target_new_stop | basis |
|--------|-----------------|-------------------|--------|-----------------|--------|
| _(none — no open positions)_ | — | — | — | — | — |

## Notes

**Outcome: ZERO planned buys, ZERO planned sells.** Defensive session — no recent earnings beat presented a clean, confirming PEAD setup clearing the raised bar. This is the "raise the bar, don't lower it" outcome, not a failure to find names.

### Gates (all PASS)
- **Clock:** `/v2/clock` is_open=false @ 2026-11-09T07:23 ET; `next_open` 2026-11-09T09:30 ET = **opens today, not a holiday** → proceed (pre_market runs pre-open by design).
- **Reconciliation 0/0 PASS:** Alpaca `/v2/positions`=[] matches portfolio.md FLAT; `/v2/orders?status=open`=[] (no orphan stops). Account ACTIVE, trading_blocked=false, equity **$94,946.98**, cash $94,946.98 (100%), buying_power $379,787.92.
- **Universe cache FRESH:** 347 tickers, screened 2026-11-08, expires 2026-11-15 (not stale).

### Posture / regime (governing thresholds this session)
- **PEAD health: ELEVATED_BAR (FRESH, not stale)** — computed 2026-11-08, expires 2026-11-15; `realized_health_60d_pct` **-0.951%**, `health_sample_n` 260, health_ok=false. → For THIS session: **EPS-surprise bar raised to >20% for ALL sectors**, and **max new positions capped at 2**. The realized PEAD drift edge is currently NOT paying (negative trailing-60d), reinforcing a defensive stance.
- **SPY 200-day regime: BULL** — SPY 735.40 (IEX; 735.29 SIP per pead_health) > 200MA 727.65. Bear-regime rule NOT active. ELEVATED_BAR cap (2) is the binding new-position cap.
- **Macro-deferral:** live pre-open S&P futures / 10yr level not independently confirmable this run; **moot** — the >20%-all-sectors bar is already enforced by ELEVATED_BAR regardless, so the macro rule cannot tighten further.
- Weekly new-position usage: **0/2** used this week (last buy VRT 2026-10-29, stopped out -8% on 2026-11-02; book FLAT since).

### Shortlist evaluation — every recent >20%-ish beat screened, none cleared ≥6/10

All candidates below are already IN the universe cache, so no non-universe watchlist flag is warranted.

- **DASH** (Consumer Disc) — adj EPS $1.06 vs ~$0.81–0.82 = **+29% surprise** (clears >20%), rev +34% YoY, net income +91%; stock +~6% on the print. **DROPPED (step d + step g):** 52-week high was **254 days ago** (Nov-2025; stock ~30% below it, -22% YTD) — the pop is **M&A-driven, not post-earnings drift**. Same morning DASH announced a **$17B acquisition of Instacart** ($65/sh, ~26% premium) — a transformative deal carrying material **antitrust/FTC** and integration/financing risk that can plausibly dominate the stock within the 42-day window. Not a PEAD setup.
- **MRNA** (Health Care) — Q3 reported 2026-11-06: GAAP EPS $0.38 vs consensus ~-$1.10 LOSS (loss→profit swing), rev $1.31B +29% YoY (beat ~$885M est), FY26 rev-growth guide raised to 15–25%; closed +5.4% (hit intraday 52wk-high ~$267 then faded to $254.49). **DROPPED — honest score ≈4/10 (<6):** (1) EPS "surprise" is a sign-flip off a loss estimate, partly R&D cost cuts — not a clean >20% positive-base beat; (2) **analyst consensus HOLD, avg PT ~$80–137 — far BELOW the ~$254 price (stock at ~2–3x consensus PT)**; no post-earnings upgrades found (Oct PT raises were pre-print); (3) forward **Q4 revenue implied ~-28% YoY** — decelerating, the opposite of accelerating drift; (4) structural COVID-vaccine revenue decline + pipeline setbacks (flu mRNA-1010 FDA refusal-to-file, norovirus miss); (5) muted overnight **gap +1.66%** (<5% despite the beat → confirmation -1); weak IEX volume 0.78x; (6) **Analyst Day Nov-12** = binary event risk 3 days out, inside the hold window; (7) only 0 drift days (reported Fri) → RS leg immeasurable. Overvalued, decelerating, event-risky — a clear pass under a defensive ELEVATED_BAR posture.
- **LLY** (Health Care) — Q3 (reported 2026-10-29): non-GAAP EPS $7.48 incl. a **$4.57 IPR&D charge** → surprise ambiguous (+12% to +39% depending on source); rev +39% YoY ($24.4B, ~$900M one-time). **DROPPED:** not a clean >20% surprise (IPR&D distortion), **FY26 non-GAAP EPS guide LOWERED** ($35–36 from $35.50–36.50), and **drift since the print is -1.36%** (6 bars; faded off the Nov-5 high). 11 days stale. Same ambiguity flagged on 2026-11-02.
- **RTX** (Industrials) — +27% EPS surprise. **DROPPED:** **negative post-earnings drift -3.36%** (7 bars), muted gap -0.46%, weak volume 0.61x; and Industrials is strategy.md's deprioritized/worst sector (2026 YTD 25% win rate, -4.82% avg; requires >20% AND streak≥2) — VRT (Industrials) just stopped out -8% last week.
- **APP** (+~9% EPS surprise) and **ANET** (+~11% EPS surprise) — **DROPPED:** both below the >20% ELEVATED_BAR bar despite strong revenue beats (earnings-driven entries must clear the EPS-surprise threshold).

### Watchlist
- Only **MRVL** is `status: active`. Next earnings 2026-11-26; last report ~2026-08-27 (~74d ago) — **no positive fundamentals signal in the last 30 days**, so it does not qualify for a fresh entry this session. No new watchlist flags (every beat screened was already a universe constituent).

### Sanity check vs strategy.md
- 0 buys → trivially compliant: cash floor (100% cash ≥10%), max concurrent (0 ≤ 8), max new-per-week (0 ≤ 2 under ELEVATED_BAR), sector caps (n/a). Nothing to trim.
